Biotech of the week: Glycotope, the Biggest Biotech in Berlin

08/01/2016 - 2 minutes

After the Christmas and New Year, we continue our journey across Europe to have a glimpse of it’s vast number of Biotechs. This week, we leave Finland behind and head South-West across the Baltic Sea and back to our home town, Berlin, to visit our biotech of the week, Glycotope.

Glycotope_kl

City: Berlin, Germany

Founded: 2001

Employees: 200 (as of 12/2015)

Financial Data: €135M Total Raised (as of 12/15)

CEO:

Mission: Glycotope is one of the World experts in glycosylation. It has 2 major missions: the First is through the use of their technologies, GlycoExpress, to develop, optimise and produce glycosylated proteins for external sources and GlycoBody, which generates antibodies with highly specific binding to tumour cells.

Their second mission is the production of antibodies and non-antibody proteins targeting cancer and infertility, with 9 candidates currently in the pipeline. Their most promising product is FSH-GEX, a non anti-body protein targeting infertility in females,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member